Smith & Nephew plc
SNN
NYSE·Healthcare·Medical - Devices·Mkt cap $12.1B
$28.87
▲ +0.63%
P/E
10.94
Mkt Cap
$12.1B
52-Wk Range
$28.48–$38.79
52-Week Range
$28.48 - $38.79
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 24.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.7).
Growth
Revenue decline expected
Value
Undervalued - trading well below sector peers
Momentum
Stable
-4.8% over 3m
Quality
Excellent
Strong fundamentals
Dividend
Solid
2.73% yield
Smart-money signal
Who's buying SNN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 4, 2026
Reported EPS of $0.95 vs $0.94 consensus (+0.8% surprise). Revenue of $3.1B vs $1.6B expected (+90.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+0.8%
Revenue trend · last 8Q
—
—
+8%
+3%
+6%
+5%
+7%
+5%
Q4 22
Q2 23
Q4 23
Q2 24
Q4 24
Q2 25
Q4 25
Q2 26
$2.6B
$2.7B
$2.8B
$2.8B
$3.0B
$3.0B
$3.2B
$3.1B
Margins · last 8Q
Gross
—
Operating
—
Profit
9.8%
Wall Street consensus
4 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
75%
Sell
25%
Median Price Target
—
Latest: Morgan Stanley · Sep 2, 2026
vs Industry
How SNN stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.